Core Viewpoint - The stock price of West Point Pharmaceuticals is reported at 34.44 yuan, reflecting a 1.00% increase from the previous trading day, indicating positive market sentiment towards the company [1] Company Summary - West Point Pharmaceuticals operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of pharmaceuticals [1] - For the first half of 2025, the company reported a revenue of 128 million yuan and a net profit attributable to shareholders of 24.94 million yuan, along with a net cash inflow from operating activities of 33.71 million yuan [1] Market Activity - On August 15, the company experienced a net outflow of 13.72 million yuan in principal funds, with a cumulative net outflow of 1.36 million yuan over the past five days, suggesting some selling pressure in the market [1]
西点药业股价小幅上扬 中报净利润2494万元